Prospective Evaluation of Patients With Pleural Effusion

Status Recruiting

Clinical Trial Summary

Having a pleural effusion is a common reason for being hospitalized, as it usually requires in-patient care for invasive diagnostic and therapeutic procedures. Specific subtypes of pleural effusion may warrant recurrent admissions, a longer hospital stay and consume more healthcare resources. Despite the recent advancement of pleural medicine, better research is increasingly desired to fill the gaps in establishing an early diagnosis and optimal management of pleural effusion from various causes. Local data on different aspects of pleural effusion is also lacking.

Clinical Trial Description

The aetiologies of pleural effusion range from cardio-respiratory diseases, malignancy, infection to systemic inflammatory conditions. However, data on the exact incidence of individual causes of pleural effusion is inadequate. Conflicting results on the aetiologies of pleural effusion were shown in several retrospective and prospective studies based in different geographical regions, which may be explained by the different epidemiology of common diseases in the corresponding areas and patients recruited. Despite a common clinical problem, the incidence and aetiology of pleural effusion have not been examined on a population level in Hong Kong. Therefore, a local study is necessary to inform physicians about the disease burden of pleural effusion. The management of pleural disease can be heterogeneous, as reflected by a recent multi-institutional questionnaire study in Hong Kong. Infrequent updates of international guidelines of pleural medicine, lack of an established registry reflecting the patient burden, procedure load and complications may contribute. Delayed or suboptimal management of pleural diseases can lead to unnecessary invasive procedures, prolonged hospital stays and even higher mortality rates. A local registry should be established to stocktake and understand diagnostic accuracy and complication rates of pleural procedures and reflects the real-life practice by hospital physicians. This prospective study aims at evaluating the aetiology and management of pleural diseases prospectively. The management by the attending doctors will not be interfered. Recruited patients will be divided into subgroups based on their characteristics for further analysis. The data collected from this study will guide the planning of subsequent research to overcome the knowledge and service gap in managing pleural diseases. ;

Study Design

Related Conditions & MeSH terms

Pleural Effusion

Clinical Trial Details

NCT number	NCT05759117
Study type	Observational [Patient Registry]
Source	Chinese University of Hong Kong
Contact	Ka Pang Chan, MBChB
Phone	35052211
Email	chankapang@cuhk.edu.hk
Status	Recruiting
Phase
Start date	September 1, 2022
Completion date	March 31, 2026

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04159831` - A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions	Phase 2
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT02045641` - Pleural and Pericardial Effusion Following Open Heart Surgery	N/A
Completed	`NCT01948076` - Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination	N/A
Completed	`NCT01416519` - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation	N/A
Completed	`NCT01560078` - Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion	N/A
Completed	`NCT04891705` - Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study
Recruiting	`NCT05910112` - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed	`NCT03896672` - Clinical Implementation of the Use of Positive Pressure in Chest Drainage	N/A
Active, not recruiting	`NCT06075836` - AI Assisted Detection of Chest X-Rays
Recruiting	`NCT03728491` - Education and Training Competences in Thoracic Ultrasound	N/A
Not yet recruiting	`NCT03260088` - Evaluation Of Pleural Effusion At Assiut University Hospital	N/A
Completed	`NCT03535883` - The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03661801` - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Completed	`NCT01778270` - Not Invasive Monitoring of Pleural Drainage	N/A
Terminated	`NCT00402896` - Malignant Pleural Effusion With ZD6474	Phase 2
Recruiting	`NCT00103766` - Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion	N/A
Completed	`NCT03327688` - Point-of-care Ultrasound in Finland	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.